As part of SNBL—Japan’s #1 nonclinical CRO—Gemseki leverages SNBL’s comprehensive resources to accelerate innovation for the pharma and biotech sectors.
Our Drug Candidate Marketplace serves as a trusted platform for licensing opportunities, showcasing a wide range of drug candidates and advanced technologies to global partners.
With a team spanning Tokyo, the U.S., Spain, and Taiwan, and expertise in Japanese, English, Chinese, and Korean, we ensure seamless communication and tailored support for our partners across more than 40 countries.
Let us help you navigate your licensing journey. Contact us at info@gemseki.com to explore how we can support your success.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Tokyo, Jp
- Phone
- +81 3 6264 0471
- Industry
- Business Consulting And Services
- NAICS
-
Management, Scientific, and Technical Consulting ServicesManagement Consulting ServicesOther Scientific and Technical Consulting ServicesOther Management Consulting Services
- Website
- gemseki.com
- HQ
- Tokyo
Gemseki Questions
Gemseki's helpline number is +81 3 6264 0471
Gemseki's website is gemseki.com
Gemseki's LinkedIn profile is https://jp.linkedin.com/company/gemseki
Gemseki has
6 employees.
View email and phone details for 6
employees at Gemseki.
Gemseki's industry is
Business Consulting and Services
Gemseki's top competitors are
Rival & Queen,
Morphmind,
（株）スコヒアファーマ,
Chaperone Investment,
Meraki Pharmacal,
Snbl,
Pacira Biosciences, Inc.,
Waterlily Turbine,
Beiley Biofund Inc.,
Xplico - Life Science Valuation.
Gemseki's categories are Business Consulting and Services
Gemseki's founding year is 2017
